Qube Research & Technologies Limited has disclosed a position in Barratt Developments PLC, representing 0.59% of the 10p ordinary shares. The disclosure, made under Rule 8.3 of the Takeover Code, indicates an increase in long positions through cash-settled derivative transactions. The disclosed dealings include a series of equity swap transactions, each increasing a long position in the 10p ordinary shares at various prices per unit.
The disclosure provides detailed information about the interests and short positions held by Qube Research & Technologies Limited in Barratt Developments PLC. It includes the number and percentage of relevant securities owned and controlled, as well as the number of cash-settled derivatives held. The disclosure also mentions that the latest practicable date prior to the disclosure was 09-04-2024.
The disclosure by Qube Research & Technologies Limited is in compliance with the regulatory requirements for public opening position disclosure and dealing disclosure by a person with interests in relevant securities representing 1% or more. It is important to note that all interests and short positions have been disclosed as per the regulatory guidelines.
The detailed breakdown of the cash-settled derivative transactions indicates a series of transactions increasing a long position in the 10p ordinary shares at various price points. The nature of the dealings, including opening/closing long/short positions and the number of securities involved, has been meticulously outlined in the disclosure.
This disclosure provides valuable insights into the recent dealings and positions held by Qube Research & Technologies Limited in Barratt Developments PLC. It offers transparency regarding the ownership and control of relevant securities, as well as the nature of the derivative transactions undertaken. The information presented in the disclosure is crucial for investors and market participants to assess the current market dynamics and the interests of significant stakeholders in Barratt Developments PLC.